Literature DB >> 24265345

Rapidly progressive cerebellar ataxia in West Wales.

Khalid Ali1, Reem Amin, Kathir G Yoganathan, Rob Powell.   

Abstract

Progressive multifocal leucoencephalopathy (PML) is a severe demyelinating disease of the central nervous system that is caused by the JC virus infection. It is often fatal or severely disabling. PML exclusively happens in the context of cell-mediated immunosuppression. Prior to the era of HIV, PML was mainly confined to patients with haematological malignancies and rheumatological diseases. The HIV epidemic in the early eighties led to massive expansion in the incidence and prevalence of the disease. PML has also been recognised to happen due to treatment with monoclonal antibodies such as natalizumab, which is used as a disease-modifying agent for relapsing remitting multiple sclerosis and other monoclonal antibodies used in dermatological and haematological conditions. The clinical picture is that of cognitive decline, visual disturbance and hemiparesis. The correct clinicoradiological picture combined with demonstrating the JC virus DNA in the cerebrospinal fluid (CSF) using PCR (PMR) is enough to establish the diagnosis. Brain biopsy is rarely needed. Immune reconstitution represents the mainstay in the treatment of PML. We present a case of a 47-year-old man who presented with progressive cerebellar ataxia. Investigations confirmed PML. He was found to be HIV positive. We also review the literature.

Entities:  

Mesh:

Year:  2013        PMID: 24265345      PMCID: PMC3841387          DOI: 10.1136/bcr-2013-201619

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  28 in total

1.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

Review 2.  Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

Authors:  Leonard H Calabrese; Eamonn S Molloy; DeRen Huang; Richard M Ransohoff
Journal:  Arthritis Rheum       Date:  2007-07

Review 3.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

4.  Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.

Authors:  T Weber; C Trebst; S Frye; P Cinque; L Vago; C J Sindic; W J Schulz-Schaeffer; H A Kretzschmar; W Enzensberger; G Hunsmann; W Lüke
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

5.  Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Authors:  R S Hamilton; M Gravell; E O Major
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 6.  The clinical features of PML.

Authors:  Joseph R Berger
Journal:  Cleve Clin J Med       Date:  2011-11       Impact factor: 2.321

Review 7.  CNS complications of AIDS: CT and MR findings.

Authors:  R G Ramsey; G K Geremia
Journal:  AJR Am J Roentgenol       Date:  1988-09       Impact factor: 3.959

Review 8.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

9.  Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.

Authors:  Eamonn S Molloy; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2009-12

10.  Seroepidemiology of the human polyomaviruses.

Authors:  Annika Stolt; Kestutis Sasnauskas; Pentti Koskela; Matti Lehtinen; Joakim Dillner
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

View more
  2 in total

Review 1.  Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.

Authors:  Martijn T Wijburg; Bob W van Oosten; Jean-Luc Murk; Ouafae Karimi; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2014-10-09       Impact factor: 6.682

2.  Atypical periodic alternating nystagmus responding to high-dose intravenous immunoglobulins: a case report.

Authors:  Herminia Argente-Escrig; Luis Bataller; Claudio Krstulovic Roa; Vanesa Pérez Guillén; Herminio Perez Garrigues; Bonaventura Casanova Estruch
Journal:  J Neuroinflammation       Date:  2017-03-31       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.